How much will a box of rasagiline cost in the market in 2025?

Rasagiline is a drug used to treat Parkinson's disease and is an irreversible monoamine oxidase inhibitor (MAO-B inhibitor). The drug works by inhibiting an enzyme in the brain called monoamine oxidaseB, thereby increasing the concentration of the neurotransmitter dopamine in the brain, helping to relieve symptoms such as tremors, stiffness and slowness of movement in patients with Parkinson's disease. Rasagiline is commonly used in patients with early or advanced Parkinson's disease, either as monotherapy or in combination with other anti-Parkinsonian drugs, with the goal of improving patients' quality of life.

Rasagiline is currently on the market in China and has been included in the national medical insurance directory. The market price varies depending on the manufacturer, dosage form and specifications. The price of domestically marketed rasagiline generally ranges from a few hundred yuan to more than a thousand yuan, while the prices of foreign versions vary greatly. For example, the price of the original version of rasagiline in Türkiye is about around 1,000 yuan, while the price of generic drugs produced in India is relatively low, about 300 yuan.

Withthe global drug market fluctuates in 2025, the price of rasagiline may be affected by a variety of factors. For example, domestic and foreign manufacturers may adjust prices due to changes in market competition and raw material costs, and medical insurance policies may also affect patients' out-of-pocket expenses. If domestic medical insurance further expands reimbursement coverage or pharmaceutical companies succeed in price negotiations, the price of rasagiline may drop, further reducing the burden on patients. In addition, the generic drug market in countries such as India is developing rapidly. If more affordable generic drugs are introduced into the country, market prices may also be affected to a certain extent.

Generally speaking, as an important drug for the treatment of Parkinson's disease, the price stability of rasagiline is closely related to medical insurance policies, market competition and production costs. When patients choose to purchase medicines, they should give priority to formal channels to ensure the quality and safety of medicines and to better control their own medication costs.

Reference materials:https://www.azilect.com/